A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
NCT06680830
Basal Ganglia Diseases, Brain Diseases
Sun City, Arizona, United States
View Trial DetailsNCT Number: NCT06536348
This is an observational, cross-sectional study with a control group, with the general objective of developing and evaluating a national database, unprecedented in Brazil, containing clinical, epidemiological, motor, and non-motor aspects of Parkinson's disease (PD). The database will be open and accessible to national and international researchers in order to contribute to the advancement of research related to PD. The aim is to collect data, in a paired way, from a control group and an experimental group. Data collection will include the application of questionnaires, the execution of motor activities, and clinical scales. Information that can identify the participants will be removed from the database for later storage in a repository. Quantitative, qualitative, and descriptive variables from the database will be estimated in order to characterise and contrast the groups studied. The results of this study will contribute to a better characterization of the staging of PD as a function of the epidemiological, motor, and non-motor aspects evaluated, as well as to the development of technologies and methods that can be applied in clinical practice.
Interested in participating?
Request Info18 year–120 year
All sexes
Observational
Laboratório de Análise de Movimento e Processamento de Sinais, Brasília, Federal District, Brazil
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
For both groups, individuals who have other neurological or musculoskeletal diseases that interfere with the execution of the tests will be excluded.
Time frame: 10 years
Sex: male, female
Time frame: 10 years
Age in years
Time frame: 10 years
Length of schooling in years
Time frame: 10 years
Weight in kg
Time frame: 10 years
Height in cm
Time frame: 10 years
Blood type: A+, A-, B+, B-, O+, O-, AB+, AB-
Time frame: 10 years
Economic rating as given by the Brazilian Economic Classification Criteria (Brazilian Criteria) - https://www.abep.org/criterioBr/01_cceb_2022_eng.pdf
Time frame: 10 years
Primary disorder classification according to the International Statistical Classification of Diseases and Related Health Problems (ICD) https://www.who.int/standards/classifications/classification-of-diseases
Time frame: 10 years
Secondary disorder according to the International Statistical Classification of Diseases and Related Health Problems (ICD) https://www.who.int/standards/classifications/classification-of-diseases
Time frame: 10 years
name and daily dose of medications
Time frame: 10 years
Is there family history related to the primary ICD? (yes, no)
Time frame: 10 years
date
Time frame: 10 years
date
Time frame: 10 years
City of residence in Brazil
Time frame: 10 years
State of residence in Brazil
Time frame: 10 years
married, single, divorced, and widowed
Time frame: 10 years
Housing classification by type of housing ownership rights: State-owned housing, Municipality-owned housing, Natural person's owned housing, Legal person's owned housing, Private renting, Other
Time frame: 10 years
The number of adults and children living in a home
Time frame: 10 years
Laterality refers to the preference for using one side of the body over the other and is most commonly associated with hand dominance, such as being right-handed or left-handed, e.g., Right-handedness, Left-handedness, Ambidexterity, Mixed-handedness (Cross-dominance).
Time frame: 10 years
Verification if the participant has had contact with one of the following devices: mobile, personal computer, mouse, webcam, keyboard, microphone, earphone.
Time frame: 10 years
Profession according to the Brazilian Classification of Occupation (https://www.mtecbo.gov.br/cbosite/pages/home.jsf)
Time frame: 10 years
Monthly wage in Brazilian Reais
Time frame: 10 years
Head movement amplitude in degrees
Time frame: 10 years
Head movement speed in degrees per second
Time frame: 10 years
Facial expression evaluation according to the Facial Action Coding System (FACS)
Time frame: 10 years
Speed and regularity of eye movement (degrees per second and latency in ms)
Time frame: 10 years
Smooth pursuit are quantified by the gain (how well the eyes follow the target in speed) and phase (distance to the target during pursuit)
Time frame: 10 years
Handwriting speed (seconds) and quality
Time frame: 10 years
Clinical scale for measuring signs and symptoms of Parkinson's disease (https://www.movementdisorders.org/MDS/MDS-Rating-Scales/MDS-Unified-Parkinsons-Disease-Rating-Scale-MDS-UPDRS.htm?gad_source=1&gclid=CjwKCAjwnqK1BhBvEiwAi7o0X6DuHrFh3qftNQ1N9AGWMkFo4BpG6b3hAFWnoh2Dwu86DPY53ZXpKRoCBRYQAvD_BwE)
Each item of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale will be evaluated as 0: Normal; 1: Slight; 2: Mild; 3: Moderate; 4: Severe.
The minimum value of the scale is 0, whereas the maximum value is 4. Higher scores mean a worse outcome.
Time frame: 10 years
Depression measured according to the Geriatric Depression Scale (GDS) https://geriatrictoolkit.missouri.edu/cog/GDS_SHORT_FORM.PDF
The Geriatric Depression Scale has 15 items. The minimum total score is zero, and the maximum is 15. Higher scores mean a worse outcome.
Time frame: 10 years
Visual Acuity measured according to the Snellen test (https://www.ncbi.nlm.nih.gov/books/NBK558961/)
Time frame: 10 years
Cognition measured according to the Montreal Cognitive Assessment (MOCA) scale
The Montreal Cognitive Assessment (MoCA) is a 30-point test. The minimum total score is zero, and the maximum is 30. Higher scores mean a better outcome.
Time frame: 10 years
Dysarthria measured according to the protocol for the evaluation of central dysartries in patients with Parkinson's Disease (https://doi.org/10.1590/S1516-18462011005000030)
Time frame: 10 years
Hand movement in degrees per second
Contact information is provided by the study sponsor or research team.
Adriano Andrade, PhD
CONTACT
Adriano Andrade, PhD
CONTACT
Federal University of Uberlandia
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06680830
Basal Ganglia Diseases, Brain Diseases
Sun City, Arizona, United States
View Trial DetailsNCT07323121
Basal Ganglia Diseases, Brain Diseases
Nanjing, Jiangsu, China
View Trial DetailsNCT04477785
Anosmia, Basal Ganglia Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT07710625
Basal Ganglia Diseases, Brain Diseases
Istanbul, Turkey, Turkey (Türkiye)
View Trial Details